Business Context and Reporting Period
This Form 8-K was filed by dMY Technology Group, Inc. IV, a special purpose acquisition company, on March 9, 2021. The filing does not identify Planet Labs PBC as the registrant; it reports the closing of dMY Technology Group IV’s initial public offering.
Key Financial and Capital Markets Metrics
| Item | Reported information |
|---|---|
| IPO units issued | 34.5 million units, including 4.5 million units issued through the underwriters’ fully exercised over-allotment option |
| IPO price and gross proceeds | $10.00 per unit; $345.0 million gross proceeds |
| Public warrants | Each unit included one-fifth of a redeemable warrant, implying 6.9 million whole public warrants; exercise price of $11.50 per share |
| Private placement warrants | 5.933 million warrants sold to dMY Sponsor IV, LLC at $1.50 per warrant, generating $8.9 million gross proceeds |
| Trust account | $345.0 million was placed in a U.S.-based trust account |
| Revenue and profitability | The filing does not provide operating revenue, net income, earnings per share, margins, or operating cash flow. |
| Debt and liquidity | The filing does not report debt balances. IPO and private-placement proceeds provide the disclosed liquidity, subject to trust-account restrictions. |
Material Changes and Unusual Items
- The company completed its IPO and the underwriters exercised the full over-allotment option.
- The company completed a private sale of 5.933 million warrants to its sponsor. These warrants have transfer restrictions, are not redeemable while held by the sponsor or permitted transferees, may be exercised on a cashless basis, and carry registration rights.
- The filing states that $338.1 million of IPO proceeds, including $12.075 million of deferred underwriting discount, and $6.9 million of private-placement proceeds were deposited into the trust account. These components total $345.0 million, but the stated $6.9 million private-placement amount differs from the separately reported $8.9 million gross private-placement proceeds; the filing text does not clearly reconcile this difference.
- The company adopted an amended and restated certificate of incorporation and entered into underwriting, warrant, trust, registration-rights, sponsor, and administrative-services agreements.
- Darla Anderson, Francesca Luthi, and Charles E. Wert were appointed as independent directors and assigned committee roles. Each received 25,000 shares of Class B common stock from the sponsor.
Outlook, Risks, and Contingencies
- The trust funds are generally restricted until the earliest of completion of an initial business combination, certain approved stockholder redemptions, or redemption of public shares if no business combination is completed within 24 months of the IPO closing.
- Public stockholders may have redemption rights in connection with a proposed business combination or certain charter amendments.
- The filing provides no operating forecast, revenue guidance, target-company disclosure, or management outlook.
- The principal contingency is the company’s ability to complete an initial business combination within the required 24-month period; otherwise, public shares are subject to redemption under the governing charter provisions.
Investor Verification Items
- Confirm the filing entity and period: this is a dMY Technology Group IV filing, not a Planet Labs PBC operating-company filing.
- Reconcile the $8.9 million gross private-placement proceeds with the $6.9 million amount stated as deposited into the trust account.
- Review the amended charter and trust agreement for redemption mechanics, deadlines, and permitted releases of funds.
- Assess dilution from public warrants, private-placement warrants, sponsor shares, and any eventual business-combination financing.
- Verify the terms and restrictions of the sponsor warrants and Class B shares before evaluating the capitalization structure.